Early Type 1 Diabetes Conference 2026
Rethinking Type 1 Diabetes: The Early Stage T1D Pivot
Friday 23rd January 2026
Edgbaston Park Hotel, University of Birmingham, UK
Join us on Friday 23rd January 2026 at the Edgbaston Park Hotel and Conference Centre in Birmingham for a one-day meeting dedicated to exploring Early -Type 1 Diabetes. This conference will bring together the diabetes MDT to discuss staging, risk, emerging therapies, psychological support, and the road ahead towards a preventative era in Type 1 Diabetes.
About the Meeting
Type 1 diabetes (T1D) has long been diagnosed only at the point of clinical onset, often after months or years. However, advances in screening, staging, and now disease-modifying therapies mean that we can identify children and young people at risk, before they need insulin.
This creates both opportunities and challenges: how do we monitor progression, communicate risk, support families, and prepare the health system for preventative therapies?
This conference will focus on the Early -diagnosis “window” of Type 1 diabetes, a pivotal stage where risk can be identified, families can be supported, and intervention may be possible. Bringing together clinicians and researchers we aim to build a shared understanding of how best to shape care and policy for this new era.
Who is this aimed at:
- Paediatric and adult diabetes clinicians
- Nurses
- Dietitians
- Clinical Psychologists and allied health professionals working with young people and adults
- Commissioners and policymakers
- Researchers in diabetes prevention and immunotherapy
Why These Topics Matter
Early Detection & Risk Stratification
Screening for autoantibodies and genetic risk factors opens the possibility of predicting T1D before clinical symptoms. Understanding how to interpret and act on these results is essential for safe and effective implementation.
Psychological Support for Families
Living with “risk” can be as emotionally demanding as living with the condition itself. Families need practical strategies, psychological support, and clear communication to navigate uncertainty and prevent distress.
Transition to Adult Care
Adolescents and young adults are particularly vulnerable to gaps in care. Exploring how Early -T1D knowledge and support can bridge into adult services ensures continuity and better outcomes.
New Therapies & Pathways
With Teplizumab now licensed as the first immunotherapy to delay T1D onset, the field is rapidly evolving. This meeting will review the latest guidance, national pathways, and therapies beyond Teplizumab.
Towards Prevention
The ultimate goal is a preventative era in Type 1 diabetes. By bringing together diverse perspectives, clinical, psychological, and experiential we move closer to this shared vision.
Sponsors
We are grateful for the generous support that helps make this meeting possible.
Main Sponsor
A special thank you to our Main Sponsor, Sanofi, for their commitment to advancing research and care in Type 1 Diabetes.
Additional Sponsors
We would also like to thank our additional sponsors, Abbott, Air Liquide, Dexcom, and Medtronic for their valued support of this meeting.
Exhibitors & Additional Support
The sponsoring company has paid for stand space to Leeds Teaching Hospitals NHS Trust (host to the Children and Young People’s Yorkshire and Humber Diabetes Network). Their contributions will support venue and catering costs for the meeting.
Important Note on Independence
The sponsoring companies have paid for stand space to Leeds Teaching Hospitals NHS Trust (host to CYP YH Diabetes Network) which will support towards venue and catering costs. The sponsoring companies have had no influence over the meeting agenda or arrangements. All scientific content and discussions have been independently developed by the National Children and Young People’s Diabetes Network to ensure transparency and integrity.